Tumor Lysate

Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer
Claudia Maletzki, Leonie Wiegele, Ingy Nassar, Jan Stenzel, Christian Junghanss

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 8; DOI: 10.1186/s40425-018-0476-x
Dendritic cell vaccine treatment for indolent B cell non-hodgkin lymphoma: clinical trial in progress
Yi Lin, Thomas Atwell, Adam Weisbrod, Mary Maas, Adam Armstrong, Michael Deeds, Peggy Bulur, Michael Gustafson, Zhe Zhang, Louis Porrata, Svetomir Markovic, Patrick Johnston, Ivana Micallef, David Inwards, Joseph Colgan, Stephen Ansell, Dennis Gastineau, Allan Dietz, Thomas Witzig

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P76; DOI: 10.1186/2051-1426-2-S3-P76
Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma
Lien Vandenberk, Abhishek D Garg, Patrizia Agostinis, Tina Verschuere, Carolien Koks, Steven De Vleeschouwer, Stefaan Van Gool

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P163; DOI: 10.1186/2051-1426-2-S3-P163
Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
Jill Gershan, Kristen Barr, James Weber, Bryon Johnson

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P74; DOI: 10.1186/2051-1426-1-S1-P74

Main menu